Trial Profile
Effect of roflumilast on cytokine profiles in patients with fibrotic pulmonary sarcoidosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jul 2017
Price :
$35
*
At a glance
- Drugs Roflumilast (Primary)
- Indications Sarcoidosis
- Focus Pharmacodynamics
- 13 Jul 2017 New trial record
- 24 May 2017 Results presented at the 113th International Conference of the American Thoracic Society